SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001479290-18-000101
Filing Date
2018-08-03
Accepted
2018-08-03 17:25:57
Documents
55
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rvncq21810q.htm 10-Q 1097741
2 EXHIBIT 10.1 rvnc-q218exhibit101.htm EX-10.1 34521
3 EXHIBIT 10.3 rvnc-q218exhibit103.htm EX-10.3 34735
4 EXHIBIT 31.1 rvnc-q218exhibit311.htm EX-31.1 13581
5 EXHIBIT 31.2 rvnc-q218exhibit312.htm EX-31.2 13481
6 EXHIBIT 32.1 rvnc-q218exhibit321.htm EX-32.1 6241
7 EXHIBIT 32.2 rvnc-q218exhibit322.htm EX-32.2 6410
  Complete submission text file 0001479290-18-000101.txt   4431192

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT rvnc-20180630.xml EX-101.INS 799584
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20180630.xsd EX-101.SCH 33189
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20180630_cal.xml EX-101.CAL 52579
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20180630_def.xml EX-101.DEF 148479
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20180630_lab.xml EX-101.LAB 420185
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20180630_pre.xml EX-101.PRE 246703
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36297 | Film No.: 18992933
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1